OUR WORK
ADEPT HAS SUPPORTED MORE THAN 60 INNOVATORS FROM ACADEMIA AND INDUSTRY WITH UNIQUE PROJECTS TO ALIGN PROMISING TECHNOLOGIES WITH UNMET CLINICAL NEEDS, WHILE ALSO CREATING OPPORTUNITIES TO ADDRESS INEQUITIES FACED BY INNOVATORS, TRAINEES AND PATIENTS.
01
Bio-Stream Diagnostics has developed a point-of-care test that uniquely leverages organic electrochemical transistor technology to detect a wide range of diagnostic biomarkers. Working with ADEPT's team, Bio-Stream has made significant strides towards adapting its platform for clinically relevant applications and launching clinical trials to demonstrate clinical utility.
02
Rapid Infection Diagnostics
RID Inc. has developed a rapid diagnostic platform that identifies the microbes that cause urinary tract and blood stream infections, as well as determining antibiotic susceptibility in under 5 hours. Through support from ADEPT's team and partners, including the Alberta Centre for Advanced Diagnostics, RID has expanded its operations, generated critical data for regulatory approval, and is preparing to launch its first clinical trial in Alberta.
03
Biosenta
Biosenta is developing an innovative antimicrobial product called "Tri-Filler", which prevents the growth of mold, viruses and bacteria. The product can be added to a variety of surfaces that are at risk of microbial contamination. Through feedback from ADEPT's team members, Biosenta has been able to focus it's commercialization strategy and has secured investments to further develop its product based on performance data generated by the Alberta Centre for Advanced Diagnostics.
04
ILLUCIDx
ILLUCIDx develops rapid and easy to use point-of-care tests for pathogen detection. The company's flagship device, White Pearl, automates sample preparation through to data visualization. Working with the ADEPT team, ILLUCIDx has advanced its platform by developing an AI algorithm to enhance its test results and has conducted clinical studies in a variety of international sites.
05
CriticareDx
CriticareDx has developed a lab-on-a-chip testing platform that uniquely combines self-powered microbluidics and electrochemical nano-biosensors for fully automated point-of-care testing. Through ADEPT's support and connection to clinical experts and end-users, CriticareDx has designed its technology to specifically meet the needs of provincial point-of-care testing programs from sample input through to health system integration. CriticareDx is now moving forward with technology assessment studies in partnership with ADEPT.
Supported Companies and Organizations
